Release Date: November 20, 2024
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Positive Points
- ReNew Energy Global PLC (RNW, Financial) reported a 14% growth in adjusted EBITDA for the quarter, driven by cost optimization.
- The company has commissioned 860 megawatts to date in this fiscal year and is on track to meet its guidance of installed megawatts.
- ReNew Energy Global PLC (RNW) has secured an external order book of over 900 megawatts, ensuring surplus capacity is sold in the market.
- The company's solar module manufacturing facilities are fully operational, with trial production of cells having started.
- ReNew Energy Global PLC (RNW) has achieved a 31% increase in profit after tax, primarily due to lower G&A and finance costs.
Negative Points
- The company's share price movement has been affected by US macro factors, despite these having little bearing on its business.
- There is a potential risk of delay in the RTC project due to transmission readiness, although the company does not currently expect this.
- ReNew Energy Global PLC (RNW) faces challenges with wind PLFs, which are down by 300 basis points, affecting performance.
- The company has legacy PPAs with lower tariffs, which may not be favorable compared to current market conditions.
- There is a significant gap in PPA conversion, with about 40 gigawatts of PPAs not signed off from all auctions.
Q & A Highlights
Q: Can you provide more details on the RTC project's timeline and potential transmission delays?
A: Sumant Sinha, CEO, confirmed that the RTC project is on track for completion in the second half of fiscal 2025, with no expected delays in transmission readiness. Some capacity might be sold in the merchant market before the PPA is fully operational, but this will be limited.
Q: How will the proposed restrictions on cell imports affect your manufacturing plans?
A: Sumant Sinha, CEO, mentioned that the government plans to impose restrictions on cell imports by April 2026. ReNew is considering expanding its cell manufacturing capacity to meet internal needs, although no final decision has been made yet.
Q: What drove the recent cost optimizations, and how do you foresee future cost reductions?
A: Kailash Vaswani, CFO, explained that cost optimizations were achieved through renegotiating OEM contracts and reducing discretionary spending. Future growth will focus on leveraging existing resources without significant additional costs.
Q: Are there any challenges with the C&I portfolio, and what are the execution timelines?
A: Sumant Sinha, CEO, stated that half of the 1.3 gigawatt C&I portfolio is expected to be commissioned this year, with the remainder next year. There are no significant challenges, and demand remains strong, particularly from large offtakers.
Q: How does the current finance cost remain stable despite increased debt?
A: Kailash Vaswani, CFO, attributed stable finance costs to firm hedges on currency exposure and refinancing high-cost debt, resulting in significant interest cost savings.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.